1. Neuregulin-1 reverses anxiety-like behavior and social behavior deficits induced by unilateral micro-injection of CoCl2 into the ventral hippocampus (vHPC)
- Author
-
Ji-Young Yoo, Han-Byeol Kim, Ye-Ji Lee, Yu-Jin Kim, Seung-Yeon Yoo, Yoori Choi, Mi-Jo Lee, In-Sik Kim, Tai-Kyoung Baik, Jun-Ho Lee, and Ran-Sook Woo
- Subjects
Neuregulin-1 ,CoCl2 ,Hypoxia ,vHPC ,Anxiety ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Neuregulin-1 (NRG1) is an epidermal growth factor family member with essential roles in the developing and adult nervous systems. In recent years, establishing evidence has collectively suggested that NRG1 is a new modulator of central nervous system (CNS) injury and disease, with multifaceted roles in neuroprotection, remyelination, neuroinflammation, and other repair mechanisms. NRG1 signaling exerts its effects via the tyrosine kinase receptors ErbB2-ErbB4. The NRG1/ErbB network in CNS pathology and repair has evolved, primarily in recent years. In the present study, we demonstrated that a unilateral microinjection of CoCl2 into the ventral hippocampus (vHPC) induced hypoxic insult and led to anxiety-related behaviors and deficit sociability in mice. NRG1 treatment significantly alleviated the CoCl2-induced increase of hypoxic-related molecules and behavioral abnormalities. Furthermore, NRG1 reduced the CoCl2-induced neuroinflammation and neuronal deficits in the vHPC or primary hippocampal neurons in mice. Collectively, these results suggest that NRG1 ameliorates hypoxia by alleviating synaptic deficits and behavioral abnormalities of the CoCl2-induced vHPC hypoxic model.
- Published
- 2023
- Full Text
- View/download PDF